# SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

> clinical trial · VERIFIED · 2026-08-11

Status: COMPLETED · Sponsor: Hangzhou Sumgen Biotech Co., Ltd. · Condition: Systemic Lupus Erythematosus (SLE)

- Company: Hangzhou Sumgen Biotech Co., Ltd.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06144710

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.